Analytic and Clinical Performance of Major Commercial Severe ...

The rapid development of commercially available molecular assays in response to the COVID-19 pandemic has been essential in identifying positive cases and ...

Semantic Scholar extracted view of "Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays ...

Analytic and Clinical Performance of Major Commercial Severe ...

Clinics in Laboratory Medicine - Vol. 42 - N° 2 - p. 129-145 - Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome ...

Analytical and clinical evaluation of four commercial SARS-CoV-2 ...

This study aimed to compare four anti-SARS-CoV-2 immunoassays in populations presenting different clinical severity levels. Three populations were included: ...

Diagnostic and analytical performance evaluation of ten commercial ...

Although most people with COVID-19 disease have mild to moderate symptoms, the disease can cause severe medical complications such as acute respiratory distress ...

Real-world clinical performance of commercial SARS-CoV-2 rapid ...

Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data ...

Meta-analysis of the clinical performance of commercial SARS-CoV ...

Reliable testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and timely reporting of the data to public health authorities ...

2023 AHA/ACC Clinical Performance and Quality Measures for ...

... main coronary artery disease: a pooled analysis of 5775 individual patient data. ... At 30 d, the composite primary endpoint of death or severe ...

2024 ACC/AHA Clinical Performance and Quality Measures for ...

Top 10 Take-Home Messages for Adults With Valvular and Structural Heart Disease. 1. The current document includes a comprehensive list of 11 ...

Newborn Screening for Severe Combined Immunodeficiency ...

analytic performance clinical performance. Newborn ... Abstract: Severe combined immunodeficiency (SCID) is characterized by a major T cell deficiency.

Clinical Testing Guidance for Dengue - CDC

For acute dengue diagnosis, clinicians should order NS1 ELISA and IgM tests or NAAT and IgM tests. If dengue is suspected, clinicians should ...

2024 Update to the 2020 ACC/AHA Clinical Performance and ...

TOP 10 TAKE-HOME MESSAGES FOR ADULTS WITH HEART FAILURE. 1. This document describes performance measures for heart failure that are appropriate ...

ACG System Overview

The Johns Hopkins ACG System is the world's leading population health analytics software. The system continues to evolve, providing ever-more refined tools.

Newborn Screening for Severe Combined Immunodeficiency ...

Newborn Screening for Severe Combined Immunodeficiency: Analytic and Clinical Performance of the T Cell Receptor Excision Circle Assay in France (DEPISTREC ...

Commercial Health Solutions | Mathematica

Cost and payment analysis; Real world evidence solutions; Manuscript development; Clinical trial dashboards for monitoring and analytics; Quality measure ...

Top 10 hospital performance metrics you need to know

According to our data, the average length of stay among short-term acute care hospitals in the U.S. was 4.9 days in 2023. Readmission rates.

Confounding factors of Alzheimer's disease plasma biomarkers and ...

However, when adding these two factors in models assessing biomarker performance for different clinical outcomes (relation to cerebrospinal ...

Selection, optimization and validation of ten chronic disease ...

Ten were selected for implementation based on PRS performance, medical actionability and potential clinical utility, including cardiometabolic diseases and ...

Information Sheet: Performance Studies with IVD - Swissmedic

- A 'performance study' is a study undertaken to establish or confirm the analytical or clinical ... clinical trial (or parts thereof) from commercial "for ...

Burden of serious harms from diagnostic error in the USA

As we reported previously, based solely on clinical studies, 'Big Three' diseases account for 75.8% of all serious harms.9 The current analysis shows these are ...